Background: Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that could favor the occurrence of small intestinal bacterial overgrowth. The aim of the study was to assess the prevalence of small intestinal bacterial overgrowth in PD patients. Methods: Consecutive PD patients were enrolled. The controls were subjects without PD. All patients and controls underwent the glucose breath test to assess small intestinal bacterial overgrowth. Results: Forty-eight PD patients and 36 controls were enrolled. The prevalence of small intestinal bacterial overgrowth was significantly higher in PD patients than in controls (54.17% vs 8.33%; P < .0001; OR, 2.24; 95% CI, 3.50-48.24). Multivariate analysis showed Hoehn and Y...
Purpose of Review: Patients suffering from Parkinson's disease (PD) are known to experience gastroin...
peer reviewedObjective: Alterations of the gut microbiome in Parkinson disease (PD) have been repeat...
Parkinson’s disease (PD) is a neurodegenerative disorder, which affects approximately 6 million indi...
Background: Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that...
BACKGROUND: Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities ...
The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abno...
We previously reported gut dysbiosis in patients with Parkinson's disease (PD).The aim of this study...
<div><p>Background</p><p>We previously reported gut dysbiosis in patients with Parkinson’s disease (...
<div><p>Background</p><p>The intestine is one of the first affected organs in Parkinson’s disease (P...
Aim: To address how common are intestinal inflammation and compromised barrier function in idiopathi...
BackgroundThere is mounting evidence for a connection between the gut and Parkinson's disease (PD). ...
Gut microbiome and colonic inflammation can be associated with the predisposition and progression of...
Pathologic and epidemiologic studies suggest that Parkinson disease (PD) may in some cases start in ...
Introduction: In recent years the hypothesis that gut microbiota associates with Parkinson's disease...
The gut microbiome recently has been associated with many diseases, with studies showing that the mi...
Purpose of Review: Patients suffering from Parkinson's disease (PD) are known to experience gastroin...
peer reviewedObjective: Alterations of the gut microbiome in Parkinson disease (PD) have been repeat...
Parkinson’s disease (PD) is a neurodegenerative disorder, which affects approximately 6 million indi...
Background: Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that...
BACKGROUND: Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities ...
The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abno...
We previously reported gut dysbiosis in patients with Parkinson's disease (PD).The aim of this study...
<div><p>Background</p><p>We previously reported gut dysbiosis in patients with Parkinson’s disease (...
<div><p>Background</p><p>The intestine is one of the first affected organs in Parkinson’s disease (P...
Aim: To address how common are intestinal inflammation and compromised barrier function in idiopathi...
BackgroundThere is mounting evidence for a connection between the gut and Parkinson's disease (PD). ...
Gut microbiome and colonic inflammation can be associated with the predisposition and progression of...
Pathologic and epidemiologic studies suggest that Parkinson disease (PD) may in some cases start in ...
Introduction: In recent years the hypothesis that gut microbiota associates with Parkinson's disease...
The gut microbiome recently has been associated with many diseases, with studies showing that the mi...
Purpose of Review: Patients suffering from Parkinson's disease (PD) are known to experience gastroin...
peer reviewedObjective: Alterations of the gut microbiome in Parkinson disease (PD) have been repeat...
Parkinson’s disease (PD) is a neurodegenerative disorder, which affects approximately 6 million indi...